Related Experiment Video
Updated: Oct 9, 2025

07:48
Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
8.9K
Arteriogenesis and Therapeutic Angiogenesis-An Update
Elisabeth Deindl1,2, Paul H A Quax3
1Walter-Brendel-Centre of Experimental Medicine, University Hospital, Ludwig-Maximilians-Universität, 81377 Munich, Germany.
International Journal of Molecular Sciences
|December 24, 2021
Summary
Vascular occlusive diseases like heart attack, lower extremity artery disease, and stroke cause significant global health issues. Research continues to seek better treatments for these widespread conditions.
Area of Science:
- Cardiovascular Science
- Vascular Medicine
- Public Health
Background:
- Vascular occlusive diseases, including myocardial infarction, peripheral artery disease, and stroke, impose a considerable global health burden.
- These conditions significantly impact patient morbidity, mortality, and healthcare costs worldwide.
- Effective management and prevention strategies are crucial for mitigating the impact of these diseases.
Discussion:
- The pathophysiology of vascular occlusion involves complex interactions between blood flow, vessel walls, and systemic factors.
- Understanding the underlying mechanisms is key to developing targeted therapeutic interventions.
- Multidisciplinary approaches are often required for comprehensive patient care.
Key Insights:
- Myocardial infarction, peripheral artery disease, and stroke are leading causes of death and disability globally.
- Early diagnosis and timely intervention are critical for improving outcomes in patients with vascular occlusive events.
- Ongoing research focuses on novel diagnostic tools and treatment modalities.
Outlook:
- Future research aims to elucidate novel therapeutic targets for vascular occlusive diseases.
- Advancements in personalized medicine hold promise for tailoring treatments to individual patient profiles.
- Public health initiatives focused on risk factor modification are essential for long-term disease prevention.
More Related Videos
Related Concept Videos
Mechanism of Angiogenesis
6.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
Regulation of Angiogenesis and Blood Supply
2.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K

